Aspire Biopharma Holdings, Inc. (ASBP) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.04M | -927.84K | -1.1M | -1.14M | -1.75M | 479.57M | -533.8M | -592.32K | -2.26M | -156.13K | -124.92K | -189.95K | -182.11K | -35.87K | -46.62K | -38.37K | -1.29M | -48 | -181 | 135.04K |
| Operating CF Margin % | -10716.76% | -21775.19% | -56868.06% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -73.48% | -100.19% | 99.79% | -92.52% | 22.5% | 307263.99% | -427208.46% | -211.83% | -1141.02% | -335.26% | -167.94% | -395.04% | 85.86% | -75318.94% | -25658.01% | -128.41% | -780459.39% | - | - | - |
| Net Income | -3.22M | -4.71M | -1.85M | -1.98M | -15.94M | 2.3M | -537.02K | -602.26K | -2.47M | -150.91K | -69.26K | 1.81M | 2.87M | 2.23M | 1.08M | 120.69K | -87.83K | -3 | -15 | -2.38K |
| Depreciation & Amortization | 1.58M | 6M | 2.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 13.41K | 0 | 0 | 0 | 14.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.58K | -262.26M | -1.59M | 260.87M | 384.52K | 477.07M | -533.03M | 38.27K | 161.46K | -251.7K | -255.48K | -2.1M | -3.17M | -2.54M | -1.32M | -418.53K | -21.39K | 0 | 0 | 700 |
| Working Capital Changes | -1.41M | 260.04M | 318.36K | -260.03M | -326.3K | 206.33K | -230.32K | -28.33K | 45.65K | 246.49K | 199.82K | 98.3K | 119.36K | 278.16K | 196.4K | 259.47K | -1.18M | -45 | -166 | 136.72K |
| Change in Receivables | 0 | 1.03M | 0 | 0 | -1.03M | 21.97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -116.81K | -253.16K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -139.53K | -126.91K | -1.32M | 0 | 1.12M | 0 | 319.61K | 219.07K | 0 | 47.63K | 2.71K | -102.06K | 0 | 84.62K | 0 | 64.71K | -36.03K | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 38.26M | 13.78M | 0 | 0 | 632.97K | 284.28M | 0 | 0 | 0 | 0 | -294.69M | 0 | 0 | -165.96K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -18.82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 52.06M | 0 | 0 | 0 | 632.97K | 284.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -165.96K |
| Cash from Financing | 7.89M | -16.53K | 2.85M | 0 | 3.09M | -492.48M | 492.48M | -13.19M | 2.26M | 155.85K | -632.97K | -284.28M | 0 | 0 | 0 | 0 | 296.59M | 48 | 182 | 30.91K |
| Debt Issued (Net) | -885.56K | -5.94M | 2.85M | 0 | 3.09M | 25.5K | -25.5K | 2.59M | 0 | 155.85K | 0 | 0 | 0 | 0 | 0 | 0 | -252.91K | 0 | 0 | 0 |
| Equity Issued (Net) | 8.95M | -265.83K | 0 | 0 | 265.83K | 13.78M | 0 | -13.78M | 0 | 0 | -284.92M | -284.28M | 0 | 0 | 0 | 0 | 297.14M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 13.78M | -13.78M | 0 | 917.25K | -632.97K | -284.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -173.91K | 6.19M | 0 | 0 | -265.83K | -506.28M | 492.5M | -2M | 2.26M | 0 | 284.28M | 0 | 0 | 0 | 0 | 0 | -298.54K | 48 | 182 | 30.91K |
| Net Change in Cash | 4.85M | -944.37K | 1.74M | -1.14M | 1.34M | -12.91M | -3.06M | -27.68M | 0 | -55.94K | -124.92K | -189.95K | -182.11K | -35.87K | -46.62K | -38.37K | 618.12K | 0 | 0 | 0 |
| Free Cash Flow | -3.04M | -927.84K | -1.1M | -1.14M | -1.75M | 2.56M | 25.5K | -592.32K | -2.26M | -156.13K | -124.92K | -189.95K | -182.11K | -35.87K | -46.62K | -38.37K | -1.29M | -48 | -181 | 135.04K |
| FCF Margin % | -10716.76% | -21775.19% | -56868.06% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -73.48% | -136.22% | -4427.98% | -92.52% | 22.5% | 1740.72% | 120.42% | -211.83% | -1141.02% | -335.26% | -167.94% | -395.04% | 85.86% | -75318.94% | -25658.01% | -128.41% | -780459.39% | - | - | - |
| FCF per Share | -2.03 | -0.62 | -0.89 | -0.92 | -1.85 | 3.71 | 0.04 | -0.86 | -3.28 | -0.25 | -0.20 | -0.24 | -0.20 | -0.04 | -0.05 | -0.04 | -2.76 | -0.00 | -0.00 | 0.17 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.20x | 0.60x | 0.58x | 0.11x | -53.70x | 994.04x | 0.98x | 0.92x | 1.03x | 1.80x | -0.10x | -0.06x | -0.02x | -0.04x | -0.32x | 14.66x | 0.06x | 0.01x | -56.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |